SciELO - Scientific Electronic Library Online

vol.67 issue1Comparison of two protocols for the management of early severe pre-eclampsia, and of maternal and neonatal outcomes: A historic cohort Hospital Universitario San José, Popayán (Colombia)Description of anxiety, hopelessness and self-esteem levels in a group of Chilean women diagnosed with primary infertility: A pilot study author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Colombiana de Obstetricia y Ginecología

Print version ISSN 0034-7434


GONZALEZ-TESHIMA, Laura Yuriko et al. Hereditary breast and ovarian cancer syndrome: Clinical application. Rev Colomb Obstet Ginecol [online]. 2016, vol.67, n.1, pp.36-49. ISSN 0034-7434.

Objective: To provide gynaecologists with tools for the identification of patients at risk of hereditary breast and ovarian cancer syndrome (HBOC) and present advise regarding the preventive management of patients with this syndrome. Materials and methods: Questions were asked in relation to the risk of patients with HBOC developing breast and ovarian cancer. To answer those questions, a review of the relevant literature was conducted in the Medline database via PubMed, and in ScienceDirect and SciELO. The MESH terms used were Breast and Ovarian Cancer Syndrome, Ovarian Neoplasms, Breast Neoplasms, BRCA1 Genes, BRCA2 Genes, and their equivalent in English. Results were limited to articles published between 2005 and 2015. Results: Overall, 56 articles were found in PubMed, of which 45 were selected. The search in ScienceDirect and SciELO resulted in 7 articles. Additionally, 4 articles from other sources not linked to these data bases were also included. Conclusions: Obstetric gynaecologists must identify patients at risk of presenting Hereditary Breast and Ovarian Cancer Syndrome, and explain to the patients the importance of performing molecular testing for BRCA1 and BRCA2 genes; and they must participate in multi-disciplinary teams consisting also of geneticists, surgeons, oncologists and patients for medical decision-making in accordance with the molecular results.

Keywords : Hereditary breast and ovarian cancer syndrome; ovarian neoplasms; breast neoplasms; BRCA1 and BRCA2 Genes.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License